This Materials Stock Is Sinking After the Dividend's Slashed 95%. Here's What's Happening.
Celanese reported third-quarter adjusted earnings of $2.44 a share on sales of $2.6 billion.
Celanese (CE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Celanese (CE) Lags Q3 Earnings and Revenue Estimates
Celanese (CE) came out with quarterly earnings of $2.44 per share, missing the Zacks Consensus Estimate of $2.84 per share. This compares to earnings of $2.50 per share a year ago.
Celanese to Report Q3 Earnings: What's in the Offing for the Stock?
CE's cost-cutting initiatives and acquisition synergies are likely to have contributed to its Q3 performance amid demand and pricing headwinds.
Celanese (CE) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Celanese (CE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Celanese (CE) Earnings Expected to Grow: Should You Buy?
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese: Sold In January 2024, Back In Again With A 'Buy'
Celanese Corporation, a specialty chemicals company, has underperformed the S&P 500 but shows potential for recovery with a solid asset base and forecasted EPS growth. Despite recent challenges, including supplier disruptions, Celanese reported improved earnings and streamlined operations, particularly in engineered materials. The company's EPS is expected to grow at an annualized rate of 18.22% until 2026, with dividends remaining stable at $2.8/share.
Bear Of The Day: Celanese (CE)
Celanese (CE) is a Zacks Rank #5 (Strong Sell) after the company missed the Zacks Consensus Estimate when the last reported on August 1 of this year. Celanese Corporation is a global hybrid chemical company.
Celanese Corp stock price prediction: Will the stock keep on falling?
Celanese Corporation (NYSE: CE) has faced a series of downgrades and reduced price targets from prominent financial institutions, reflecting growing concerns about the company's performance in a challenging global environment. Most recently, on 5 September, analysts at Piper Sandler downgraded Celanese from Overweight to Neutral, lowering the price target from $180 to $150.
Celanese Corporation: Margin Expansion Story Doesn't Offset Leverage Risks
Celanese is a global producer of specialty chemicals and material products that are involved in several end markets and for a wide range of applications globally. The company reported lower revenues and earnings per share in its recent Q2'24 results, with declines in both the Engineered Materials and Acetyl Chain businesses. Despite challenges, EBITDA grew 18% due to cost synergies, leading to margin expansion.
Celanese Corporation (CE) Q2 2024 Earnings Call Transcript
Celanese Corporation (NYSE:CE ) Q2 2024 Earnings Conference Call August 2, 2024 11:00 AM ET Company Participants Bill Cunningham - VP of IR Lori Ryerkerk - Chairman of the Board and CEO Scott Richardson - COO Chuck Kyrish - CFO Conference Call Participants Josh Spector - UBS Mike Sison - Wells Fargo Mike Leithead - Barclays Jeff Zekauskas - JPMorgan Ghansham Panjabi - Baird Arun Viswanathan - RBC Capital Markets Vincent Andrews - Morgan Stanley Matthew Hettwer - Vertical Research Partners Aleksey Yefremov - KeyBanc Capital Markets David Begleiter - Deutsche Bank Hassan Ahmed - Alembic Global Salvator Tiano - Bank of America Laurence Alexander - Jefferies Patrick Cunningham - Citi John Roberts - Mizuho Securities John McNulty - BMO Capital Markets Operator Greetings and welcome to Celanese's Second Quarter 2024 Earnings Call and Webcast. [Operator Instructions].
Celanese (CE) Q2 Earnings and Sales Fall Short of Estimates
The decline in net sales of Celanese (CE) in Q2 is a result of a decrease in pricing.
